Open access
Sep 2026
Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study
Doxorubicin is an effective chemotherapeutic agent, whose clinical use is limited by cumulative doxorubicin-induced cardiotoxicity. Early identification of myocardial injury is essential to prevent irreversible cardiac dysfunction. This study evaluated changes in cardiac function and circulating biomarkers associat...
Lakshmi V. Divya, Ashok Govindaraj, Anita Ramesh Chandra et al.
· The Indian journal of medica... · 0 citations